2,339
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2205956 | Received 12 Jan 2023, Accepted 18 Apr 2023, Published online: 03 May 2023

References

  • Vinker Shuster M, Gendelman O, Tiosano S, et al. Ischemic heart disease and ankylosing spondylitis-assessing the role of inflammation. Clin Rheumatol. 2018;37(4):1–10.
  • Martin-Martinez MA, Castaneda S, Gonzalez-Juanatey C, et al. Incidence of first cardiovascular event in spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project. Clin Exp Rheumatol. 2019;37(5):731–739.
  • Kerola AM, Rollefstad S, Semb AG. Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment. Eur Cardiol. 2021;16(:e18.
  • Midtbø H, Gerdts E, Berg IJ, et al. Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. J Rheumatol. 2018;45(9):1249–1255.
  • Baniaamam M, Heslinga SC, Boekel L, et al. The prevalence of cardiac diseases in a contemporary large cohort of dutch elderly ankylosing spondylitis Patients-The CARDAS study. J Clin Med. 2021;10(21):5069.
  • Wibetoe G, Ikdahl E, Rollefstad S, et al. Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther. 2017;19(1):153.
  • Liew JW, Jafarzadeh SR, Dubreuil M, et al. The association of tumor necrosis factor inhibitor use with incident hypertension in ankylosing spondylitis: data from the PSOAS cohort. J Rheumatol. 2022;49(3):274–280.
  • Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the european association of cardiovascular imaging (EACVI) and the American society of echocardiography (ASE)dagger. Eur Heart J Cardiovasc Imaging. 2015;16(6):577–605.
  • Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the european society of cardiology and the european society of hypertension. Blood Press. 2018;27(6):314–340.
  • Ikdahl E, Rollefstad S, Wibetoe G, et al. Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol. 2016;43(9):1622–1630.
  • Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9(6):809–815.
  • Svanteson M, Rollefstad S, Kløw NE, et al. Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases. PLoS One. 2019;14(12):e0226479.
  • Berg IJ, Semb AG, van der Heijde D, et al. Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study. Semin Arthritis Rheum. 2014;44(3):309–313.
  • Berg IJ, van der Heijde D, Dagfinrud H, et al. Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study. J Rheumatol. 2015;42(4):645–653.
  • van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–368.
  • Feldtkeller E, Erlendsson J. Definition of disease duration in ankylosing spondylitis. Rheumatol Int. 2008;28(7):693–696.
  • Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–2291.
  • van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(12):1811–1818.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1–39 e14.
  • Perrone-Filardi P, Coca A, Galderisi M, et al. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus paper from the european association of cardiovascular imaging (EACVI), the european society of cardiology council on hypertension, and the european society of hypertension (ESH). Eur Heart J Cardiovasc Imaging. 2017;18(9):945–960.
  • de Simone G, Izzo R, Chinali M, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010;56(1):99–104.
  • Gerdts E, Rossebø AB, Pedersen TR, et al. Relation of left ventricular mass to prognosis in initially asymptomatic mild to moderate aortic valve stenosis. Circ Cardiovasc Imaging. 2015;8(11):e003644.
  • Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–448.
  • Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol. 2013;40(4):359–368.
  • Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). an update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th european stroke conferences, mannheim, Germany, 2004, brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290–296.
  • Midtbø H, Semb AG, Matre K, et al. Left ventricular systolic myocardial function in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2019;71(9):1276–1283.
  • Berger M, Fesler P, Roubille C. Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. Autoimmun Rev. 2021;20(9):102891.
  • Dalbeni A, Giollo A, Tagetti A, et al. Traditional cardiovascular risk factors or inflammation: which factors accelerate atherosclerosis in arthritis patients? Int J Cardiol. 2017;236:488–492. (
  • Föhse FK, Rollefstad S, Ikdahl E, et al. Degree of arterial stiffness is comparable across inflammatory joint disease entities. Scand J Rheumatol. 2022;51(3):186–195.
  • Forsblad-d’Elia H, Law L, Bengtsson K, et al. Biomechanical properties of common carotid arteries assessed by circumferential 2D strain and β stiffness index in patients with ankylosing spondylitis. J Rheumatol. 2021;48(3):352–360.
  • Navarini L, Caso F, Costa L, et al. Cardiovascular risk prediction in ankylosing spondylitis: from traditional scores to machine learning assessment. Rheumatol Ther. 2020;7(4):867–882.
  • Lønnebakken MT, Izzo R, Mancusi C, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania salute network). J Am Heart Assoc. 2017;6(3):e004152.
  • Os HA, Rollefstad S, Gerdts E, et al. Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. Rheumatology (Oxford). 2020;59(12):3700–3708.
  • Lønnebakken MT, Mancusi C, Losi MA, et al. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: the Campania salute network. Nutr Metab Cardiovasc Dis. 2019;29(2):185–190.
  • Grymyr LMD, Nadirpour S, Gerdts E, et al. One-year impact of bariatric surgery on left ventricular mechanics: results from the prospective FatWest study. European Heart Journal Open. 2021;1(2):1–10.
  • Kringeland E, Tell GS, Midtbø H, et al. Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland health study. Blood Press. 2020;29(5):267–275.
  • Liew JW, Gianfrancesco MA, Heckbert SR, et al. Relationship between body mass index, disease activity, and exercise in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2021;74(8):1287–1293.
  • Galderisi M, Henein MY, D’Hooge J, et al. Recommendations of the european association of echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes. Eur J Echocardiogr. 2011;12(5):339–353.